Legacy Cancer Institute Medical Oncology and Day Treatment is a clinical research site located in Vancouver, Washington, United States 98684.
Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Legacy Cancer Institute Medical Oncology and Day Treatment has participated in 43 clinical trials with 34 currently active.
Therapeutic areas: Malignant Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Chemotherapy-Induced Peripheral Neuropathy.
Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), NRG Oncology.
Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Legacy Cancer Institute Medical Oncology and Day Treatment has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Legacy Cancer Institute Medical Oncology and Day Treatment has 43 clinical trials on record, with 34 currently active. Their work covers Malignant Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Chemotherapy-Induced Peripheral Neuropathy.
Yes — Legacy Cancer Institute Medical Oncology and Day Treatment holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.